BIOMARIN PHARMACEUTICAL INC
BMRN
DELAYED 1 MONTH

14 insider filings · Latest: Jun 2, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
May 7, 2026May 11 9:01 PMGregory R FribergEVP, Chief R&D Officer
Sale
3,281$53.85$176.7K51,818(D)

View →

Mar 11, 2026Mar 12 11:55 PMCharles Greg GuyerEVP, Chief Technical Officer
Sale
16,486$60.46$996.7K79,953(D)

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Mar 16, 2026Mar 18 12:50 AMCharles Greg GuyerEVP, Chief Technical Officer
Grant/Award
35,680$57.4335,680(D)

View →

Mar 16, 2026Mar 18 12:45 AMBrian MuellerEVP, Chief Financial Officer
Grant/Award
44,600$57.4344,600(D)

View →